BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19434623)

  • 1. Early adversity in chronic depression: clinical correlates and response to pharmacotherapy.
    Klein DN; Arnow BA; Barkin JL; Dowling F; Kocsis JH; Leon AC; Manber R; Rothbaum BO; Trivedi MH; Wisniewski SR
    Depress Anxiety; 2009; 26(8):701-10. PubMed ID: 19434623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
    Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
    J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
    Sung SC; Wisniewski SR; Balasubramani GK; Zisook S; Kurian B; Warden D; Trivedi MH; Rush AJ;
    Psychol Med; 2013 May; 43(5):945-60. PubMed ID: 23228340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report.
    Sung SC; Wisniewski SR; Luther JF; Trivedi MH; Rush AJ;
    J Affect Disord; 2015 Mar; 174():157-64. PubMed ID: 25497473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
    Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
    J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.
    Bobo WV; Chen H; Trivedi MH; Stewart JW; Nierenberg AA; Fava M; Kurian BT; Warden D; Morris DW; Luther JF; Husain MM; Cook IA; Lesser IM; Kornstein SG; Wisniewski SR; Rush AJ; Shelton RC
    J Affect Disord; 2011 Oct; 133(3):467-76. PubMed ID: 21601287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort.
    Davis LL; Rush JA; Wisniewski SR; Rice K; Cassano P; Jewell ME; Biggs MM; Shores-Wilson K; Balasubramani GK; Husain MM; Quitkin FM; McGrath PJ
    Compr Psychiatry; 2005; 46(2):81-9. PubMed ID: 15723023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach.
    Chekroud AM; Gueorguieva R; Krumholz HM; Trivedi MH; Krystal JH; McCarthy G
    JAMA Psychiatry; 2017 Apr; 74(4):370-378. PubMed ID: 28241180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
    Friedman ES; Davis LL; Zisook S; Wisniewski SR; Trivedi MH; Fava M; Rush AJ;
    Eur Neuropsychopharmacol; 2012 Mar; 22(3):183-99. PubMed ID: 21920711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
    Blier P; Ward HE; Tremblay P; Laberge L; Hébert C; Bergeron R
    Am J Psychiatry; 2010 Mar; 167(3):281-8. PubMed ID: 20008946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining antidepressant medications: a good idea?
    Rush AJ
    Am J Psychiatry; 2010 Mar; 167(3):241-3. PubMed ID: 20194484
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].
    Gourion D
    Encephale; 2008 Jan; 34(1):73-81. PubMed ID: 18514154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.
    Williams LM; Rush AJ; Koslow SH; Wisniewski SR; Cooper NJ; Nemeroff CB; Schatzberg AF; Gordon E
    Trials; 2011 Jan; 12():4. PubMed ID: 21208417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.
    Fava M; Rush AJ; Alpert JE; Balasubramani GK; Wisniewski SR; Carmin CN; Biggs MM; Zisook S; Leuchter A; Howland R; Warden D; Trivedi MH
    Am J Psychiatry; 2008 Mar; 165(3):342-51. PubMed ID: 18172020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.
    Davis LL; Pilkinton P; Wisniewski SR; Trivedi MH; Gaynes BN; Howland RH; Zisook S; Balasubramani GK; Fava M; Rush AJ
    Depress Anxiety; 2012 Feb; 29(2):111-22. PubMed ID: 22495941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
    Warden D; Trivedi MH; Carmody T; Toups M; Zisook S; Lesser I; Myers A; Kurian KR; Morris D; Rush AJ
    J Psychiatr Pract; 2014 Mar; 20(2):118-32. PubMed ID: 24638046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
    Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
    Rush AJ; Wisniewski SR; Warden D; Luther JF; Davis LL; Fava M; Nierenberg AA; Trivedi MH
    Arch Gen Psychiatry; 2008 Aug; 65(8):870-80. PubMed ID: 18678792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Al-Adwani A
    Can J Psychiatry; 2005 Nov; 50(13):877; author reply 877-8. PubMed ID: 16483124
    [No Abstract]   [Full Text] [Related]  

  • 20. Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.
    Sheffrin M; Driscoll HC; Lenze EJ; Mulsant BH; Pollock BG; Miller MD; Butters MA; Dew MA; Reynolds CF
    J Clin Psychiatry; 2009 Feb; 70(2):208-13. PubMed ID: 19210951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.